Will inter partes review speed US generic drug entry?

被引:0
|
作者
Jonathan J Darrow
Reed F Beall
Aaron S Kesselheim
机构
[1] Jonathan J. Darrow,Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine
[2] Reed F. Beall and Aaron S. Kesselheim are at the Program On Regulation,undefined
[3] Therapeutics,undefined
[4] And Law (PORTAL),undefined
[5] Brigham and Women's Hospital and Harvard Medical School,undefined
[6] Boston,undefined
[7] Massachusetts,undefined
[8] USA.,undefined
来源
Nature Biotechnology | 2017年 / 35卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
A new extra-judicial pathway for challenging pharmaceutical patents has intensified patent challenges and helped to clear the way for earlier generic entry.
引用
收藏
页码:1139 / 1141
页数:2
相关论文
共 50 条
  • [1] Will inter partes review speed US generic drug entry?
    Darrow, Jonathan J.
    Beall, Reed F.
    Kesselheim, Aaron S.
    [J]. NATURE BIOTECHNOLOGY, 2017, 35 (12) : 1139 - 1141
  • [2] US Supreme Court upholds constitutionality of inter partes review
    Macedo, Charles R.
    Hahm, Jung S.
    Goldberg, David P.
    Lisiewski, Christopher
    Sturm, Chandler
    [J]. JOURNAL OF INTELLECTUAL PROPERTY LAW & PRACTICE, 2018, 13 (10) : 766 - 768
  • [3] Drug patent expirations and the speed of generic entry
    Bae, JP
    [J]. HEALTH SERVICES RESEARCH, 1997, 32 (01) : 87 - 101
  • [4] Patent Validity and Litigation: Evidence from US Inter Partes Review
    Helmers, Christian
    Love, Brian J.
    [J]. JOURNAL OF LAW & ECONOMICS, 2023, 66 (01): : 53 - 81
  • [5] Inter partes review: considerations for Abbreviated New Drug Application cases
    Carson, Patricia
    Taylor, Scott
    [J]. PHARMACEUTICAL PATENT ANALYST, 2014, 3 (02) : 125 - 127
  • [6] Considerations and strategies for inter partes review
    Nye-Perkins, Debra D.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [7] Prior Art in Inter Partes Review
    Yelderman, Stephen
    [J]. IOWA LAW REVIEW, 2019, 104 (05) : 2705 - 2734
  • [8] Inter Partes Review: Patent Killer No More?
    Chen, Feng-Chi
    Lee, Pin-Shen
    [J]. TRENDS IN BIOTECHNOLOGY, 2019, 37 (07) : 680 - 683
  • [9] Inter partes review: The story so far
    Bone, Richard
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [10] Understanding the fine points of inter partes review
    Blount, Jennifer
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248